Rationale, design, and baseline characteristics of a trial of prevention of cardiovascular and renal disease with fosinopril and pravastatin in nonhypertensive, nonhypercholesterolemic subjects with microalbuminuria (the Prevention of REnal and Vascular ENdstage Disease Intervention Trial [PREVEND IT]).
Source:http://linkedlifedata.com/resource/pubmed/id/10980214
Am. J. Cardiol.
2000
Sep
15
86
6
635-8
